Researchers conducted a phase 2/3 randomized clinical trial to better understand the effects of a calcitonin gene-related peptide receptor antagonist for the prevention of migraine.
Researchers have announced a possible new method of treating multiple sclerosis, which could also lead to new pharmacological options for treating the condition.
Researchers have discovered a mechanism that leads to the degradation of upper motor neurons, cells linked to the development of amyotrophic lateral sclerosis.
Researchers have discovered a mechanism that leads to the degradation of upper motor neurons, cells linked to the development of amyotrophic lateral sclerosis.
A recent study found that rimegepant, an orally administered calcitonin gene-related peptide receptor antagonist, is safe and well-tolerated for up to 52 weeks in individuals with migraine, with no signs of...
